| Metric | შპს ნიუ ფარმა | სს საქართველოს ბანკი |
|---|---|---|
| Growth | ||
| Revenue | ₾14.6m₾21.9m | ₾2.70bn₾2.32bn |
| Revenue growth | -33.2% | 16.6% |
| Profitability | ||
| EBITDA | -₾27k₾3.5m | — |
| EBITDA margin | -0.2%15.8% | — |
| Net profit | -₾1.2m₾2.1m | ₾1.84bn₾1.33bn |
| Net margin | -8.4%9.7% | 68.1%57.6% |
| Balance sheet | ||
| Total assets | ₾9.7m₾10.9m | ₾39.27bn₾31.39bn |
| Total equity | ₾3.4m₾5.9m | ₾5.63bn₾4.45bn |
| ROE | -35.4%36.1% | 32.6%30.0% |